Access the full text.
Sign up today, get DeepDyve free for 14 days.
Maoxin Wu, T. Putti, T. Bhuiya (2002)
Comparative Study in the Expression of p53, EGFR, TGF-&agr;, and Cyclin D1 in Verrucous Carcinoma, Verrucous Hyperplasia, and Squamous Cell Carcinoma of Head and Neck RegionApplied Immunohistochemistry & Molecular Morphology, 10
D. Shin, Jhingook Kim, J. Ro, Jason Hittelman, J. Roth, W. Hong, W. Hittelman (1994)
Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.Cancer research, 54 2
R. Verheijen, H. Kuijpers, R. Schlingemann, A. Boehmer, R. Driel, G. Brakenhoff, F. Ramaekers (1989)
Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase.Journal of cell science, 92 ( Pt 1)
J. Bagan, F. Vera-Sempere, Milian Ma, M. Peñarrocha, A. Peydró (1988)
Verrucous carcinoma of the oral cavity.Revue de stomatologie et de chirurgie maxillo-faciale, 89 2
J. Batsakis, R. Hybels, J. Crissman, D. Rice (1982)
The pathology of head and neck tumors: verrucous carcinoma, Part 15.Head & neck surgery, 5 1
Rong Guan, Yineng Fu, Peter Holt, A. Pardee (1999)
Association of K-ras mutations with p16 methylation in human colon cancer.Gastroenterology, 116 5
C. Sherr (2001)
The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2
Carsten Schlfiter, M. Duchrow, C. Wohlenberg, M. Becker, Gsran Key, H. Flad, J. Gerdes (1993)
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteinsThe Journal of Cell Biology, 123
G. Foye, M. Marsh, S. Minkowitz (1969)
Verrucous Carcinoma of the VulvaObstetrics & Gynecology, 34
Y. Kuratomi, Y. Kumamoto, Y. Sakai, S. Komiyama (2007)
Carotid body tumor associated with differentiated thyroid carcinomaEuropean Archives of Oto-Rhino-Laryngology, 251
Tadashi Saito, Takashi Nakajima, Kenji Mogi (2007)
Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 28 5
J. Califano, G. Clayman, D. Sidransky, W. Koch, S. Piantadosi, Peter Riet, Homaira Nawroz, W. Westra, R. Corio (1996)
Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field CancerizationOtolaryngology- Head and Neck Surgery, 115
W. Bogomoletz, François Potet, Georges Molas (1985)
Condylomata acuminata, giant condyloma acuminatum (Buschke‐Loewenstein tumour) and verrucous squamous carcinoma of the perianal and anorectal region: a continuous precancerous spectrum?Histopathology, 9
J. Ahomadegbe, M. Barrois, S. Fogel, M. Bihan, S. Douc-Rasy, P. Duvillard, J. Armand, Guy Riou (1995)
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.Oncogene, 10 6
H. Japaze, T. Dinh, J. Woodruff (1982)
Verrucous Carcinoma of the Vulva: Study of 24 CasesObstetrics & Gynecology, 60
(2002)
Comparative study in the expression of p53, EGFR, TGF-ϰ and cyclin D1 in verrucous carcinoma, verrucous hyperplasia and squamous cell carcinoma of head and neck region
P. Tazzari, A. Bontadini, M. Gobbi, C. Tassi, A. Dinota, G. Visani, M. Michieli, S. Pileri, M. Baccarani, S. Tura (1990)
Comparison of the DNA Content, Bromodeoxyuridine Incorporation and Ki-67 Antigen Expression in Human Acute Myeloid Leukemia.Leukemia & lymphoma, 3 1
F. Agha, L. Weatherbee, J. Sams (1984)
Verrucous carcinoma of the esophagus.The American journal of gastroenterology, 79 11
E. Florin, R. Kolbusz, L. Goldberg (1994)
VERRUCOUS CARCINOMA OF THE ORAL CAVITYInternational Journal of Dermatology, 33
Z. Pavelic, Y. Li, P. Stambrook, J. Mcdonald, E. Munck-Wikland, K. Pavelić, S. Dacic, Ž. Danilović, L. Pavelic, R. Mugge (1994)
Overexpression of p53 protein is common in premalignant head and neck lesions.Anticancer research, 14 5B
A. Reed, J. Califano, P. Cairns, W. Westra, R. Jones, W. Koch, S. Ahrendt, Y. Eby, D. Sewell, Homaira Nawroz, J. Bartek, D. Sidransky (1996)
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.Cancer research, 56 16
K. Szymanska, P. Hainaut (2003)
TP53 and mutations in human cancer.Acta biochimica Polonica, 50 1
P. Ellsworth, A. Schned, J. Heaney, P. Snyder (1995)
Surgical treatment of verrucous carcinoma of the bladder unassociated with bilharzial cystitis: case report and literature review.The Journal of urology, 153 2
Jay Boyle, J. Hakim, W. Koch, P. Riet, R. Hruban, R. Roa, Russell Correo, Y. Eby, J. Ruppert, D. Sidransky (1993)
The incidence of p53 mutations increases with progression of head and neck cancer.Cancer research, 53 19
D. Maccallum, P. Hall (2000)
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycleThe Journal of Pathology, 190
(2002)
Ki-67 protein: the immaculate deception? Histopathology
Jk Field, Da Spandidos, A. Malliri, Jr Gosney, M. Yiagnisis, PM Stell (1991)
Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.British Journal of Cancer, 64
A. Ferlito, G. Antonutto, F. Silvestri (1976)
Histological appearances and nuclear DNA content of verrucous squamous cell carcinoma of the larynx.ORL; journal for oto-rhino-laryngology and its related specialties, 38 2
J. Yeager, R. Findlay, I. McAleer (1990)
Penile verrucous carcinoma.Archives of dermatology, 126 9
P. Keng, D. Siemann (1998)
Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods.Radiation oncology investigations, 6 3
M. Goodrick, N. Anderson, I. Fraser, A. Rouse, V. Pearson (1992)
History of previous drug misuse in HCV-positive blood donorsThe Lancet, 339
J. Cooper, H. Hellquist, L. Michaels (1992)
Image analysis in the discrimination of verrucous carcinoma and squamous papillomaThe Journal of Pathology, 166
Li Wang, S. Shi, Qi Zhou, Susan Goldstein, Jun-yan Hong, Peter Shao, S. Qiu, Chung Yang (1994)
Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric‐cardia carcinogenesisInternational Journal of Cancer, 59
David Johnson, C. Walker (1999)
Cyclins and cell cycle checkpoints.Annual review of pharmacology and toxicology, 39
H. Rutz, R. Mirimanoff (1994)
Clinical implications of the p53 tumor-suppressor gene.The New England journal of medicine, 330 12
N. Smith, J. Rubenstein, S. Eggener, J. Kozlowski (2003)
The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.The Journal of urology, 169 4
A. Vidal, A. Koff (2000)
Cell-cycle inhibitors: three families united by a common cause.Gene, 247 1-2
N. Braun, T. Papadopoulos, H. Müller-hermelink (1988)
Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cellsVirchows Archiv B, 56
Yulian Wu, Hongyu Luo, Nada Kanaan, Jiangping Wu (2000)
The proteasome controls the expression of a proliferation‐associated nuclear antigen Ki‐67Journal of Cellular Biochemistry, 76
Q. Zhan, F. Carrier, A. Fornace (1993)
Induction of Cellular p53 Activity by DNA-Damaging Agents and Growth ArrestMolecular and Cellular Biology, 13
A. Haque, S. Syed, S. Lele, D. Freeman, P. Adegboyega (2002)
Immunohistochemical Study of Thyroid Transcription Factor-1 and HER2/ neu in Non–Small Cell Lung Cancer: Strong Thyroid Transcription Factor-1 Expression Predicts Better SurvivalApplied Immunohistochemistry & Molecular Morphology, 10
M. Lörz, E. Meyer-Breiting, R. Bettinger (2004)
Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancerEuropean Archives of Oto-Rhino-Laryngology, 251
(1991)
The p53 tumour suppressor gene. Nature (Lond)
P. Hepburn, E. Glynne‐Jones, L. Goddard, J. Gee, M. Harper (2004)
Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNAThe Histochemical Journal, 27
MD JENNINGS, A. Barclay, Watson Clinic, Fla. Lakeland (1972)
Verrucous carcinoma of the cervixCancer, 30
I. Gimenez-Conti, A. Collet, H. Lanfranchi, M. Itoiz, M. Luna, Hong‐Ji Xu, S. Hu, W. Benedict, C. Conti (1996)
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomasCancer, 78
J. Rocco, D. Sidransky (2001)
p16(MTS-1/CDKN2/INK4a) in cancer progression.Experimental cell research, 264 1
M. Gasco, S. Shami, T. Crook (2002)
The p53 pathway in breast cancerBreast Cancer Research : BCR, 4
C. Sherr (2000)
The Pezcoller lecture: cancer cell cycles revisited.Cancer research, 60 14
(1985)
Condylomata acuminata, giant condyloma acuminatum (Buschke-Lowenstein tumour) and verrucous squamous carcinoma of the perianal and anorectal region. A continuous precancerous spectrum? Histopathology
A. Jones, N. Roland, A. Caslin, T. Cooke, L. Cooke, G. Forster (1994)
A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neckThe Journal of Laryngology & Otology, 108
G. Wilson, M. Saunders, S. Dische, F. Daley, B. Robinson, C. Martindale, B. Joiner, P. Richman (1996)
Direct comparison of bromodeoxyuridine and Ki‐67 labelling indices in human tumoursCell Proliferation, 29
S. Ortega, Marcos Malumbres, M. Barbacid (2002)
Cyclin D-dependent kinases, INK4 inhibitors and cancer.Biochimica et biophysica acta, 1602 1
J. Field, D. Spandidos, P. Stell (1992)
Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinkingThe Lancet, 339
D. Brown, K. Gatter (2002)
Ki67 protein: the immaculate deception?Histopathology, 40
C. Guillot, N. Falette, Marie-Pierre Paperin, S. Courtois, A. Gentil‐Perret, I. Treilleux, M. Ozturk, A. Puisieux (1997)
p21WAF1/CIP1 response to genotoxic agents in wild-type TP53 expressing breast primary tumoursOncogene, 14
K. Steck, A. El-Naggar (1994)
Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.Cytometry, 17 3
M. Wilson, E. Anderson, J. Bell, J. Pearson, N. Haboubi, R. James, P. Schofield (1994)
An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.Surgical oncology, 3 5
J. Medina, W. Dichtel, M. Luna (1984)
Verrucous-squamous carcinomas of the oral cavity. A clinicopathologic study of 104 cases.Archives of otolaryngology, 110 7
R. Steele, R. Steele, Alastair Thompson, P. Hall, D. Lane (1998)
The p53 tumour suppressor geneBritish Journal of Surgery, 85
D. Rose, P Maddox, D Brown (1994)
Which proliferation markers for routine immunohistology? A comparison of five antibodies.Journal of Clinical Pathology, 47
A. Ferlito, G. Recher (1980)
Ackerman's tumor (verrucous carcinoma) of the larynx. A clinicopathologic study of 77 casesCancer, 46
I. Reingold, Byron Smith, J. Graham (1978)
Epithelioma cuniculatum pedis, a variant of squamous cell carcinoma.American journal of clinical pathology, 69 5
J. Gerdes, H. Lemke, H. Baisch, H. Wacker, U. Schwab, H. Stein (1984)
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.Journal of immunology, 133 4
C. Reznikoff, Thomas Yeager, C. Belair, E. Savelieva, J. Puthenveettil, Walter Stadler (1996)
Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.Cancer research, 56 13
RESEARCH Diagnostic Utility of Cell Cycle and Apoptosis Regulatory Proteins in Verrucous Squamous Carcinoma Patrick A. Adegboyega, MD,* Nahal Boromound, MD,* and Daniel H. Freeman, PhD† may be helpful in resolving diagnostic problems associated with ver- Abstract: A major problem in the diagnosis of verrucous squamous rucous carcinoma. cell carcinoma is the lack of readily reproducible objective criteria for Key Words: apoptosis, squamous cell carcinoma, verrucous caraci- distinguishing this malignant lesion from reactive epithelial hyperpla- noma, acanthosis, p16, p21, p53, Ki67 sia. Both lesions are characterized by thickened (well-differentiated) squamous epithelium without cellular atypia and subjacent stroma (Appl Immunohistochem Mol Morphol 2005;13:171–177) densely infiltrated by lymphocytes and plasma cells. This study was carried out to evaluate the use of cell cycle and apoptosis-related regu- errucous carcinoma was first described by Ackerman in latory proteins in the diagnosis of verrucous carcinoma. The study V1948 as a variant of squamous cell carcinoma of the oral materials consisted of representative formalin-fixed and paraffin- embedded tissue blocks from 19 cases of verrucous carcinoma, 18 cavity. Since then, it has also been described at other sites in classic squamous cell carcinoma, and 14 squamous epithelial hyper- the head and neck and upper aerodigestive regions,
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Jun 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.